Pharmafile Logo
Pharmafocus logo
Advanced Search
BMS building

Bristol-Myers Squibb enters academic R&D tie-up

November 4, 2015
Research and Development BMS, Bristol-Myers Squibb, Cardioxy, John Hopkins, acquisition, immunooncology, job losses

Bristol-Myers Squibb and The Johns Hopkins University have entered into a collaboration agreement, as part of the pharma firm’s rare …

News
MRI obese overweight

Novo Nordisk forms academic partnership with Washington Uni

November 4, 2015
Research and Development Novo Nordisk, diabetes, obesity

Novo Nordisk has launched a new research collaboration with researchers at the University of Washington, to develop new drugs for …

News
Prof Paul Workman

Putting off-patent drugs back to work

November 4, 2015
Research and Development, Sales and Marketing Off-Patent Drugs Bill, Professor Paul Workman, The ICR, The ICR London, drug repurposing, patents

Six clinicians here at The Institute of Cancer Research, London, have joined colleagues from across the UK in writing to …

Feature
GSK building

GSK and Merck to study immunotherapy combo in solid tumours

November 3, 2015
Research and Development GSK, Merck, immunooncology, immunotherapy, keytruda, phase I

GSK and Merck will start a Phase I clinical trial in humans to evaluate GSK’s investigational cancer drugs with the …

News
paul_oliver_cfo_biocity

Pharma R&D hub BioCity appoints new CFO

November 3, 2015
Manufacturing and Production, Research and Development, Sales and Marketing BioCity, Paul Oliver

BioCity, the UK bioscience incubator, has appointed Paul Oliver as chief financial officer as it prepares to grow across its …

Appointment

Sanofi claims $109m impact on revenue following recall

November 3, 2015
Manufacturing and Production Sanofi, finance, maufacturing, product recall

As Sanofi recalls its Auvi-Q epinephrine injection for the treatment of severe allergic reactions – after the company found the …

News
Europe Member State flags

EU plans export waiver for pharma manufacturing

November 3, 2015
Manufacturing and Production EGA, European Commission, biologics, biosimilars, generics, manufacturing, supplementary protection certificates

The European Commission plans to bring in an export waiver for supplementary protection certificates, in order to boost pharma industry …

News
R&D

Sanofi and BioNTech in cancer immunotherapy partnership

November 3, 2015
Manufacturing and Production, Research and Development BioNTech, Cancer, Sanofi, immunotherapy

Sanofi and BioNTech have agreed a new multi-year exclusive collaboration and license agreement, to discover and develop up to five …

News

Mylan appoints a global commercial lead for OTC business

November 3, 2015
Manufacturing and Production Mylan, OTC, Ranjan Ray Chaudhuri, over the counter

Mylan has appointed Ranjan Ray Chaudhuri as its new global commercial lead for the company’s over-the-counter (OTC) business. Chaudhuri will …

Appointment
China manufacturing

FDA alleges records cover-up at Chinese Pfizer plant

November 3, 2015
Manufacturing and Production FDA, Pfizer, compliance, inspection, manufacturing, production, regulations

The FDA has discovered violations at a Pfizer plant in China, including the use of out-of-date materials and record- keeping …

News
3D printer

Featured market report: 3D printing market summary

November 2, 2015
Manufacturing and Production 3d printing, manufacturing, medical devices, production

The global 3D printing medical devices market is estimated to grow at a CAGR of 25.3% from 2015 to 2020.The …

Feature
Shire

Shire to acquire Dyax in $5.9 billion deal

November 2, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Dyax, M&A, MA, R&D, Shire, hereditary angioedema, rare disease

Shire has struck a deal to acquire the biotech firm Dyax for $5.9 billion, in order to acquire exclusive rights …

News
neil_brewis_photo

Biopharma firm F-star appoints Dr Neil Brewis as CSO

November 2, 2015
Manufacturing and Production, Research and Development F-star, Neil Brewis

F-star, a biopharma company focused on immuno-oncology, has hired Dr Neil Brewis as chief scientific officer. Dr Brewis is a former vice …

Appointment
mark_filip

Former Deputy Attorney General called in to advise Valeant after fraud allegations

November 2, 2015
Medical Communications, Sales and Marketing Mark Filip, Philidor, Valeant, fraud

Valeant Pharmaceuticals’ board of directors has appointed former Deputy Attorney General of the United States Mark Filip to advise the …

Appointment
Allergan

Allergan subsidiary president arrested on kickback charges

November 2, 2015
Sales and Marketing Allergan, US District Court, Warner Chilcott, fraud, healthcare fraud

Allergan subsidiary Warner Chilcott will plead guilty to a US felony charge of healthcare fraud, and settle a case of …

News
EU flag

European Commission funds €23m project to develop HIV vaccine

November 2, 2015
Research and Development, Sales and Marketing BioNTech, European Commission, HIV, R&D, horizon 2020

The European Commission has kicked-off a new €23 million research program to bring together researchers to work on a potential …

News
eylea

Bayer, Regeneron’s Eylea gets additional EU indication

November 2, 2015
Research and Development, Sales and Marketing Bayer, Eylea, Regeneron

The European Commission has granted a fifth indication to Bayer and Regeneron’s eye drug Eylea (aflibercept injection), which is now …

News
Vidaza product image

Celgene’s Vidaza earns wider approval

November 2, 2015
Sales and Marketing Celgene, European Commission, Vidaza, acute myeloid leukaemia, azacitidine, leukaemia

Swiss firm Celgene has been given approval by the European Commission to extend its marketing authorisation for the cancer treatment …

News
Merck R&D

Merck and Selvita form oncology partnership

November 2, 2015
Research and Development, Sales and Marketing Merck, Selvita, collaboration, oncology

Merck has entered a three-year agreement with Selvita to validate new therapeutic concepts in the field of oncology. The aim …

News
abbvie_0

AbbVie reports 26% rise in Q3 revenues

October 30, 2015
Sales and Marketing AbbVie, Humira

AbbVie has announced stronger-than-anticipated Q3 financial results, its revenues increasing 26.2% on the same period last year to $5.944 billion, …

News
The Gateway to Local Adoption Series

Latest content

Japanese pharma outsources earlier as peptide development challenges grow

April 29, 2026

Study suggests phospholipid therapy may impact fatty liver disease outcomes

April 29, 2026

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026

New web series explores path from ophthalmic research to patient access

April 28, 2026

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026